SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Q32 Bio to participate in upcoming September investor conferences

Q32 Bio Inc. said management will participate in upcoming September investor conferences. The company is focused on developing therapies for alopecia areata and other autoimmune and inflammatory diseases.

QTTB

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories